Calcium-Channel Blockers (Dihydropyridines) May Increase Kidney Risk in Diabetes Patients
Recent studies link dihydropyridine calcium-channel blockers (DHP-CCBs) to elevated kidney risk in patients with diabetic kidney disease (DKD), prompting urgent reevaluation of hypertension management in type 2 diabetes. The findings, ... Read More